According to Ramer and colleagues [33], and as further reviewed by Heider et al. [37], CBD significantly attenuates ICAM-1-dependent lung cancer (A549, H358, and H460 NSCLC) cell invasion via cannabinoid receptors, TRPV1, and p42/44 MAPK. The gene discussed is TRPV1; the disease is lung cancer.